Digestive System Diseases: Clinical Trials

46,411 trials for Digestive System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22106 completed, 8974 unknown, 5726 recruiting, 3418 terminated. 12650 Not applicable, 10694 Phase 2, 5929 Phase 1, 4510 Phase 3, 2464 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable12650Completed 5823, Unknown 2758, Recruiting 1616, Not yet recruiting 767, Terminated 707, Active not recruiting 401, Withdrawn 394, Enrolling by invitation 135, Suspended 49
Phase 210694Completed 4763, Unknown 1774, Recruiting 1343, Terminated 1250, Active not recruiting 533, Not yet recruiting 524, Withdrawn 434, Suspended 48, Enrolling by invitation 25
Phase 15929Completed 3094, Recruiting 734, Terminated 717, Unknown 621, Active not recruiting 289, Withdrawn 227, Not yet recruiting 199, Suspended 37, Enrolling by invitation 11
Phase 34510Completed 2380, Unknown 765, Recruiting 442, Terminated 414, Active not recruiting 211, Not yet recruiting 146, Withdrawn 127, Suspended 13, Enrolling by invitation 12
Phase 42464Completed 1305, Unknown 549, Terminated 203, Recruiting 149, Withdrawn 106, Not yet recruiting 97, Active not recruiting 42, Enrolling by invitation 10, Suspended 3
Early Phase 1483Completed 150, Unknown 106, Recruiting 75, Terminated 43, Not yet recruiting 39, Withdrawn 29, Active not recruiting 28, Enrolling by invitation 9, Suspended 4

Follow Digestive System Diseases: new trials by email Literature Review of Digestive System Diseases trials Research Report on Digestive System Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
certepetide, nab-paclitaxel, gemcitabine - Pancreas Cancer, Pancreatic Carcinoma
Phase 1 / Phase 2WithdrawnLisata Therapeutics, Inc.2030-01-012025-06-06
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam - Ulcerative Colitis
Phase 4Not yet recruitingBausch Health Americas, Inc.1002029-06-012026-10-06
Bilio-pancreatic Complications of Congenital Duodenal Obstructions
duodenal atresia - Duodenal Obstruction
Not yet recruitingUniversity Hospital, Angers4502028-12-012026-02-10
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
Adaptive Neoadjuvant Therapy for Esophageal Cancer
Neoadjuvant concurrent chemoradiotherapy - Esophageal Carcinoma, Neoadjuvant Therapy
Not applicableEnrolling by invitationCancer Hospital Chinese Academy of Medical Science, Shenzhen Center432028-03-012025-05-25
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
Shared Decision Making using a Patient Decision Aid. - Shared Decision Making, Colonic Polyp
Phase 2Not yet recruitingVejle Hospital1102028-02-012026-04-30
AI-Enabled Mobile App for Safe Eating in Older Adults With Dysphagia
AI-Enabled Mobile Application plus Standard Care, Standard Dysphagia Education - Deglutition Disorders, Dysphagia
Not applicableNot yet recruitingKAM Chi Shan Anna3322028-01-012026-09-23
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
Umbilical cord Mesenchymal stem cell, Steroid, Standard Medical Treatment - Acute-On-Chronic Liver Failure
Phase 3Not yet recruitingInstitute of Liver and Biliary Sciences, India1002028-01-012025-08-17
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Caloric Restriction, Hyperglycemic clamp - Type2diabetes
Phase 2Not yet recruitingAdrian Vella202027-12-152026-10-28
CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer
CA102N, TAS-102, Bevacizumab - Metastatic Colorectal Cancer
Phase 2SuspendedHoly Stone Healthcare Co., Ltd1002027-12-012026-09-18
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
intravoxel incoherent motion magnetic resonance imaging - Rectal Neoplasms, Prognosis
Not yet recruitingSichuan Cancer Hospital and Research Institute4002027-11-012025-12-08
Liver Steatosis in Pediatric CD Patients
Gluten-free diet - Celiac Disease in Children, Non-Alcoholic Fatty Liver Disease
RecruitingUniversity of Palermo912027-11-012026-05-01
Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
Clinical Intervention or Procedure, Electronic Health Record Review, Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas - Pancreatic Neoplasm, Pancreatic Neuroendocrine Tumor
Not applicableEnrolling by invitationOhio State University Comprehensive Cancer Center122027-10-012026-10-13
Oral Fosamprenavir for GERD
Fosamprenavir Calcium 700 MG Oral Tablet, Placebo - Refractory Gastroesophageal Reflux Disease, Gastroesophageal Reflux Disease
Phase 2Not yet recruitingMedical College of Wisconsin602027-10-012026-09-10
DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure
blood sampling, Blood sampling - Renal Impairment, Digestive Cancers
Not yet recruitingCentre Hospitalier Universitaire de Besancon7422027-10-012026-11-02
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
Shuganhuazhuo Formula, Targeted therapy, Immunotherapy - HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine
Phase 2Not yet recruitingXiang-Qian1202027-09-012026-08-27
A Mindfulness-based Stress Reduction Program for IBD
Mindfulness based stress reduction, Active Control - Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Not applicableNot yet recruitingNova Scotia Health Authority702027-09-012026-09-08

Showing 20 of 46411. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (6121)  ·  Pancreatic Neoplasms (3679)  ·  Carcinoma, Hepatocellular (3376)  ·  Stomach Neoplasms (3177)  ·  Colonic Neoplasms (2382)  ·  Rectal Neoplasms (2239)  ·  Crohn Disease (1947)  ·  Esophageal Neoplasms (1844)  ·  Colitis, Ulcerative (1792)  ·  Hepatitis C (1721)  ·  Non-alcoholic Fatty Liver Disease (1598)  ·  Cystic Fibrosis (1583)  ·  Inflammatory Bowel Diseases (1547)  ·  Neoplasms (1342)  ·  Liver Neoplasms (1289)

Broader conditions

Gastrointestinal Diseases (25985)  ·  Neoplasms by Site (21713)  ·  Digestive System Neoplasms (21584)  ·  Neoplasms (21352)  ·  Intestinal Diseases (17024)  ·  Gastrointestinal Neoplasms (13759)  ·  Liver Diseases (12353)  ·  Pathological Conditions, Signs and Symptoms (11613)  ·  Colonic Diseases (10784)  ·  Intestinal Neoplasms (9347)  ·  Rectal Diseases (8691)  ·  Pathologic Processes (8331)  ·  Neoplasms by Histologic Type (6584)  ·  Pancreatic Diseases (6274)

Interventions

Oxaliplatin (1280)  ·  Fluorouracil (1223)  ·  Capecitabine (996)  ·  Gemcitabine (918)  ·  Leucovorin (873)  ·  Bevacizumab (812)  ·  Irinotecan (753)  ·  Ribavirin (673)  ·  Cisplatin (632)  ·  Radiotherapy (533)  ·  Cetuximab (459)  ·  peginterferon alfa-2a (428)  ·  pembrolizumab (419)  ·  Paclitaxel (372)  ·  Blood Specimen Collection (343)

Sponsors

National Cancer Institute (NCI) (504)  ·  Sun Yat-sen University (422)  ·  Mayo Clinic (367)  ·  Fudan University (366)  ·  Assiut University (361)  ·  GlaxoSmithKline (360)  ·  Merck Sharp & Dohme LLC (318)  ·  Hoffmann-La Roche (311)  ·  M.D. Anderson Cancer Center (310)  ·  AstraZeneca (291)  ·  National Taiwan University Hospital (283)  ·  Assistance Publique - Hôpitaux de Paris (276)  ·  Gilead Sciences (254)  ·  Memorial Sloan Kettering Cancer Center (238)  ·  Bristol-Myers Squibb (237)

Countries

United States (14209)  ·  China (7632)  ·  France (3625)  ·  United Kingdom (2716)  ·  Italy (2643)  ·  Canada (2642)  ·  Germany (2533)  ·  South Korea (2462)  ·  Spain (2367)  ·  Belgium (1689)  ·  Netherlands (1529)  ·  Taiwan (1451)  ·  Australia (1410)  ·  Japan (1166)  ·  Poland (1134)

Results publications

PMID 40243391, PMID 37983082, PMID 33331662, PMID 33538338, PMID 37467180, PMID 30739368, PMID 35623069, PMID 39863139, PMID 24275240, PMID 26808342, PMID 30207593, PMID 40357993, PMID 22825366, PMID 30977945, PMID 36306483, PMID 12049862, PMID 30012435, PMID 30923816, PMID 40013523, PMID 40341124, PMID 15273542, PMID 15496622, PMID 24533607, PMID 25430806, PMID 28193518, PMID 29380251, PMID 29461687, PMID 31568620, PMID 32445184, PMID 35588252, PMID 37162250, PMID 11981766, PMID 19192962, PMID 19735233, PMID 28427875, PMID 30529905, PMID 33735508, PMID 36318027, PMID 37319354, PMID 12540794, PMID 18650514, PMID 25625764, PMID 25694210, PMID 26893500, PMID 27144617, PMID 29377566, PMID 29404492, PMID 29433850, PMID 29628281, PMID 31268130

NIH funding

2023 (207), 2016 (170), 2019 (165), 2017 (160), 2015 (159), 2014 (146), 2025 (137), 2018 (130), 2009 (106), 2008 (85), P30CA033572 (50), P30CA015083 (45), P30CA016672 (45), P30CA014089 (34), U10CA032102 (32)